Quality Assurance for Duchenne and Becker Muscular Dystrophy Genetic Testing
نویسندگان
چکیده
منابع مشابه
Genetic Testing for Duchenne and Becker Muscular Dystrophy
PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that are considered investigational or cosmetic. Providers may bill members for services or procedures that are considered investigational or cosmetic. Providers are encouraged to inform members before rendering such services that the members are likely to be financially responsible for the cost of these se...
متن کاملGenetic Testing for Duchenne and Becker Muscular Dystrophy
Genetic testing for DMD gene mutations may be considered MEDICALLY NECESSARY under the following conditions: In a male with signs and symptoms of a dystrophinopathy in order to confirm the diagnosis and direct treatment. For at-risk female relatives: o To confirm or exclude the need for cardiac surveillance o For preconception testing to determine the likelihood of an affected offspring in ...
متن کاملGenetic Testing for Duchenne and Becker Muscular Dystrophy
©2017 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 15 Applies to all products admin...
متن کاملGenetic Testing for Duchenne and Becker Muscular Dystrophy
PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that are considered investigational or cosmetic. Providers may bill members for services or procedures that are considered investigational or cosmetic. Providers are encouraged to inform members before rendering such services that the members are likely to be financially responsible for the cost of these se...
متن کاملQuality assurance for Duchenne and Becker muscular dystrophy genetic testing: development of a genomic DNA reference material panel.
Duchenne and Becker muscular dystrophies (DMD/BMD) are allelic X-linked recessive disorders that affect approximately 1 in 3500 and 1 in 20,000 male individuals, respectively. Approximately 65% of patients with DMD have deletions, 7% to 10% have duplications, and 25% to 30% have point mutations in one or more of the 79 exons of the dystrophin gene. Most clinical genetics laboratories test for d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Molecular Diagnostics
سال: 2011
ISSN: 1525-1578
DOI: 10.1016/j.jmoldx.2010.11.018